{
    "nctId": "NCT03663153",
    "briefTitle": "SEMA4C as a Relapse Biomarker in Breast Cancer",
    "officialTitle": "SEMA4C as a Relapse Biomarker in Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 4200,
    "primaryOutcomeMeasure": "diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of SEMA4C in predicting recurrence of breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Have histologically confirmed new diagnosis of breast cancer according to biopsy or surgery\n\nExclusion Criteria:\n\n* Patients who are not mentally capable of giving written informed consent\n* Serum samples doesn't qualified\n* Patients who refuse follow-up on their conditions\n* Patients with prior cancer history\n* Patients with a diagnosis of other severe acute or chronic medical may increase the risk associated with study participation or may interfere with the interpretation of the study results and, in the judgement of the Investigator, would make the patient inappropriate for enrollment in this study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}